BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 8, 2025
See today's BioWorld MedTech
Home
» First quarter of 2024 sees med-tech deals rise year over year to $390.36M
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Med-tech deals 1Q24
First quarter of 2024 sees med-tech deals rise year over year to $390.36M
June 13, 2024
By
Amanda Lanier
In 2023, med-tech deals culminated in the highest total deal value ever recorded by
BioWorld MedTech
, totaling $10.63 billion, a 33% increase from the $7.99 billion recorded in 2022.
BioWorld MedTech
Analysis and data insight
Deals and M&A
